DexCom falls 7% to $71.99 after receiving warning letter from FDA
EST DexCom (DXCM) falls 7% to $71.99 after receiving warning letter from FDADiscover the Best Stocks and Maximize Your Portfolio: See ...
DexCom Options Trading: A Deep Dive into Market Sentiment
Taking into account the Volume and Open Interest on these contracts, it appears that whales have been targeting a price range ...
Fierce Biotech3d
Dexcom receives FDA warning letter over CGM manufacturing issues
Dexcom has received a warning letter from the FDA, after the agency uncovered issues during two inspections of the continuous ...
Yahoo Finance4d
DexCom (NasdaqGS:DXCM) Shares Dip 1% Despite 7% Sales Growth
The announcement came after a quarter where DexCom reported a 7% increase in sales, though net income declined significantly alongside a reduction in earnings per share. During the past quarter ...
Dexcom receives FDA warning letter for two U.S. manufacturing facilities
Medical device maker Dexcom said it has received a warning letter from the U.S. Food and Drug Administration following ...